Outset Medical (OM) Return on Capital Employed (2020 - 2026)
Outset Medical's (OM) quarterly Return on Capital Employed came in at 30.65% in Q1 2026, up 587.0% year-on-year from 4.46% in Q1 2025, and down 7.15% on a QoQ basis from 28.6% in Q4 2025.
Outset Medical (OM) Return on Capital Employed (2020 - 2026) Analysis & Trends
Outset Medical (OM) has 7 years of Return on Capital Employed data on file, last reported at 30.65% in Q1 2026.
- On a quarterly basis, Return on Capital Employed rose 587.0% year-over-year to 30.65% in Q1 2026; TTM through Mar 2026 was 30.65%, a 587.0% increase from a year earlier, with the FY2025 full-year figure at 28.69%, up 1677.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 30.65%, down from 28.6% in the prior quarter.
- Over the last five years, Return on Capital Employed for OM reached as high as 28.6% in Q4 2025 and fell as low as 66.48% in Q4 2023.
- Historically, Return on Capital Employed has averaged 45.46% across 5 years, with a median of 48.53% in 2022.
- Across the five-year window, Return on Capital Employed sank 2188 bps in 2022 and soared 2190 bps in 2025, its largest moves.
- Year by year, Return on Capital Employed stood at 48.65% in 2022, then plunged by 37 bps to 66.48% in 2023, then grew by 29 bps to 47.44% in 2024, then surged by 40 bps to 28.6% in 2025, then retreated by 7 bps to 30.65% in 2026.
- Per Business Quant data, the three most recent Return on Capital Employed figures were 30.65% in Q1 2026, 28.6% in Q4 2025, and 28.89% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 24.24% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 9.30% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 8.38% |
| 10 | Outset Medical | 80,106.28 | -286.56 Mn | 12.10 Mn | -30.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.65% |
| Dec 31, 2025 | -28.60% |
| Sep 30, 2025 | -28.89% |
| Jun 30, 2025 | -30.59% |
| Mar 31, 2025 | -36.52% |
| Dec 31, 2024 | -47.44% |
| Sep 30, 2024 | -49.32% |
| Jun 30, 2024 | -52.44% |
| Mar 31, 2024 | -58.42% |
| Dec 31, 2023 | -66.48% |
| Sep 30, 2023 | -64.28% |
| Jun 30, 2023 | -55.98% |
| Mar 31, 2023 | -49.84% |
| Dec 31, 2022 | -48.65% |
| Sep 30, 2022 | -48.53% |
| Jun 30, 2022 | -41.84% |
| Mar 31, 2022 | -34.44% |
| Dec 31, 2021 | -30.75% |
| Sep 30, 2021 | -26.64% |
| Jun 30, 2021 | -32.42% |